2 results
Approved WMOCompleted
Primary: To determine whether treatment with BKM120 plus fulvestrant prolongs PFS based on local investigator assessment compared to treatment with placebo plus fulvestrant for all patients regardless of PI3K pathway activation status (unkown status…
Approved WMOWill not start
Evaluate the performance of the Agili-C in the repair of Cartilage and Osteochondral defects.